AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019
December 10 2018 - 4:01PM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access,
peripheral vascular disease, and oncology, today announced that it
will report financial results for the second quarter of fiscal year
2019 before the market open on Friday, January 4, 2019. The
Company’s management will host a conference call at 8:00 a.m. ET
the same day to discuss the results.
To participate in the conference call, dial 1-877-407-0784
(domestic) or 1-201-689-8560 (international) and refer to the
passcode 13685683.
This conference call will also be webcast and can be accessed
from the “Investors” section of the AngioDynamics website at
www.angiodynamics.com. The webcast replay of the call will be
available at the same site approximately one hour after the end of
the call.
A recording of the call will also be available from 11:00 a.m.
ET on Friday, January 4, 2019, until 11:59 p.m. ET on Friday,
January 11, 2019. To hear this recording, dial 1-844-512-2921
(domestic) or 1-412-317-6671 (international) and enter the passcode
13685683.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative,
minimally invasive medical devices used by professional healthcare
providers for vascular access, peripheral vascular
disease, and oncology. AngioDynamics’ diverse product
lines include market-leading ablation systems, fluid management
systems, vascular access products, angiographic products and
accessories, drainage products, thrombolytic products and venous
products. For more information,
visit www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181210005730/en/
Investor Contact:AngioDynamics, Inc.Michael Greiner, Executive
Vice President & CFO(518) 795-1821
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Aug 2024 to Sep 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Sep 2023 to Sep 2024